Your browser doesn't support javascript.
Adverse events after anti-COVID-19 vaccine administration: a six-month experience.
Gaspari, Valeria; Viviani, Filippo; Baraldi, Carlotta; Neri, Iria; Orioni, Gionathan; Pileri, Alessandro.
  • Gaspari V; Unit of Dermatology, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale (DIMES), Alma Mater Studiorum University, IRCCS AOU of Bologna, Bologna, Italia.
  • Viviani F; Unit of Dermatology, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale (DIMES), Alma Mater Studiorum University, IRCCS AOU of Bologna, Bologna, Italia.
  • Baraldi C; Unit of Dermatology, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale (DIMES), Alma Mater Studiorum University, IRCCS AOU of Bologna, Bologna, Italia.
  • Neri I; Unit of Dermatology, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale (DIMES), Alma Mater Studiorum University, IRCCS AOU of Bologna, Bologna, Italia.
  • Orioni G; Unit of Dermatology, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale (DIMES), Alma Mater Studiorum University, IRCCS AOU of Bologna, Bologna, Italia.
  • Pileri A; Unit of Dermatology, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale (DIMES), Alma Mater Studiorum University, IRCCS AOU of Bologna, Bologna, Italia - alessandro.pileri2@unibo.it.
Ital J Dermatol Venerol ; 157(4): 368-369, 2022 08.
Article in English | MEDLINE | ID: covidwho-1975640

Full text: Available Collection: International databases Database: MEDLINE Main subject: Adverse Drug Reaction Reporting Systems / COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Ital J Dermatol Venerol Year: 2022 Document Type: Article Affiliation country: S2784-8671.22.07215-2

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Adverse Drug Reaction Reporting Systems / COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Ital J Dermatol Venerol Year: 2022 Document Type: Article Affiliation country: S2784-8671.22.07215-2